Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN).
Carbonari DM, Saine ME, Newcomb CW, Blak B, Roy JA, Haynes K, Wood J, Gallagher AM, Bhullar H, Cardillo S, Hennessy S, Strom BL, Lo Re V 3rd. Carbonari DM, et al. Among authors: bhullar h. Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):999-1003. doi: 10.1002/pds.3844. Epub 2015 Jul 27. Pharmacoepidemiol Drug Saf. 2015. PMID: 26213344
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies.
Lo Re V 3rd, Haynes K, Ming EE, Wood Ives J, Horne LN, Fortier K, Carbonari DM, Hennessy S, Cardillo S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Roy J, Freeman CP, Razzaghi H, Holick CN, Esposito DB, Van Staa TP, Bhullar H, Strom BL. Lo Re V 3rd, et al. Among authors: bhullar h. Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1202-15. doi: 10.1002/pds.3318. Epub 2012 Jul 5. Pharmacoepidemiol Drug Saf. 2012. PMID: 22763953
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.
Lo Re V, Carbonari DM, Saine ME, Newcomb CW, Roy JA, Liu Q, Wu Q, Cardillo S, Haynes K, Kimmel SE, Reese PP, Margolis DJ, Apter AJ, Reddy KR, Hennessy S, Bhullar H, Gallagher AM, Esposito DB, Strom BL. Lo Re V, et al. Among authors: bhullar h. BMJ Open Diabetes Res Care. 2017 Jul 31;5(1):e000400. doi: 10.1136/bmjdrc-2017-000400. eCollection 2017. BMJ Open Diabetes Res Care. 2017. PMID: 28878934 Free PMC article.
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs.
Saine ME, Carbonari DM, Newcomb CW, Nezamzadeh MS, Haynes K, Roy JA, Cardillo S, Hennessy S, Holick CN, Esposito DB, Gallagher AM, Bhullar H, Strom BL, Lo Re V 3rd. Saine ME, et al. Among authors: bhullar h. BMC Pharmacol Toxicol. 2015 Apr 2;16:8. doi: 10.1186/s40360-015-0007-z. BMC Pharmacol Toxicol. 2015. PMID: 25889498 Free PMC article.
Outcome of renal replacement therapy in the very elderly.
Munshi SK, Vijayakumar N, Taub NA, Bhullar H, Lo TC, Warwick G. Munshi SK, et al. Among authors: bhullar h. Nephrol Dial Transplant. 2001 Jan;16(1):128-33. doi: 10.1093/ndt/16.1.128. Nephrol Dial Transplant. 2001. PMID: 11209006
Reproducibility and automatic measurement of QT dispersion.
Glancy JM, Weston PJ, Bhullar HK, Garratt CJ, Woods KL, de Bono DP. Glancy JM, et al. Among authors: bhullar hk. Eur Heart J. 1996 Jul;17(7):1035-9. doi: 10.1093/oxfordjournals.eurheartj.a014999. Eur Heart J. 1996. PMID: 8809521
35 results